Carepoint Lab, LLC

Carepoint Lab, LLC was paid $3.00M by Medicaid between Mar 2023 and May 2024, across 18 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 66% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Georgia

Rank by total paid#17 of 66

Median peer was paid$178K

This provider vs. median17×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2023	119,349	$3.00M
2024incomplete	296	$2K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	66%	45,626	15,340	$1.99M
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	18%	25,722	9,996	$527K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	10.0%	40,355	13,706	$299K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	3.3%	4,543	2,477	$99K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.8%	3,103	1,831	$83K
81418		<1%	35	30	$599.22
81226		<1%	18	13	$360.73
81225		<1%	18	13	$233.09
81227		<1%	18	13	$139.85
81401		<1%	18	13	$109.60
81241		<1%	18	13	$58.70
81240		<1%	18	13	$52.55

6 more codes

81291		<1%	18	$52.27
81355		0%	18	$0.00
81479	Unlisted molecular pathology procedure	0%	63	$0.00
81328		0%	18	$0.00
81230		0%	18	$0.00
81231		0%	18	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAUSTIN, MYAH (DIRECTOR OF OPERATIONS)